Microcosm: E. coli and the New Science of Life

Last updated
Microcosm: E. coli and the New Science of Life
Microcosm E. coli and the New Science of Life.jpg
Microcosm Book Cover
Author Carl Zimmer
IllustratorTadeusz Majewski
Cover artistM. Kristen Bearse
CountryUnited States
LanguageEnglish
Subject Genetics
GenreNon-fiction
Publisher Pantheon Books
Publication date
May 6, 2008
Media typeHardcover
Pages256
ISBN 978-0-375-42430-4
579.3 42
LC Class QR82.E6 Z56 2008
Preceded byThe Descent of Man: The Concise Edition (2007) 
Followed byThe Tangled Bank: An Introduction to Evolution (2009) 

Microcosm: E. coli and the New Science of Life is a 2008 book by science writer Carl Zimmer. The book presents an overview of genetics research and genetic engineering by telling the story about the Escherichia coli (E. coli) species of bacteria which is omnipresent in the mammalian gastrointestinal tract. The title Microcosm refers to the notion that insights derived from the study of a relatively simple, single-celled organism like E. coli play in describing the fundamental features of all terrestrial life, including humans. [1]

Contents

Overview

Microcosm explores the history of E. coli's role as a popular organism to study for researchers that has revealed how genes work and are regulated giving insight into evolution, behaviour and ecology. [2] [3] Beginning at its discovery in 1885 by pediatrician and microbiologist Theodor Escherich, through isolation of the strain K12 by Edward Tatum, and leading to the numerous Nobel prize winning research based on the K12 strain and its progeny, the book recounts the large number of scientific discoveries that have relied on this simple organism. [4] The book continues on to reviews of modern and ongoing research leveraging E. coli including details about research exploring cellular nanomachines such as flagella and the composition and utility of microbial biofilms. [4]

Evolution vs. Intelligent Design

The book makes the case that the flagellum and antibiotic resistance evolved and continue to evolve due to selection pressure. [3] [2] Zimmer devotes considerable attention to phenotypic plasticity and natural selection in E. coli genesis and notes that selection can be powered by humans individually (e.g., by antibiotic administration), collectively (e.g., by large-scale industrial food production), or inadvertently (e.g., by acting as host to a microbial pathogen). [4] The book refutes the notion of intelligent design as the source of novel features of the organism, such as the flagellum that are capable of propelling E. coli, by exploring examples of more primitive, intermediate forms that, while useful, fall short of full utility of propulsion.

Though not a scientist himself, the acknowledgment section suggests that Zimmer’s theses have been vetted by multiple members of current E. coli researchers. [4]

Publication

Microcosm: E. coli and the New Science of Life was first published by Pantheon Books on May 6, 2008 in hardcover format. A Reprint edition in softcover was subsequently published in by Vintage Books in 2009.

Related Research Articles

<span class="mw-page-title-main">Antibiotic</span> Antimicrobial substance active against bacteria

An antibiotic is a type of antimicrobial substance active against bacteria. It is the most important type of antibacterial agent for fighting bacterial infections, and antibiotic medications are widely used in the treatment and prevention of such infections. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza; drugs which inhibit growth of viruses are termed antiviral drugs or antivirals rather than antibiotics. They are also not effective against fungi; drugs which inhibit growth of fungi are called antifungal drugs.

<span class="mw-page-title-main">Irreducible complexity</span> Argument by proponents of intelligent design

Irreducible complexity (IC) is the argument that certain biological systems with multiple interacting parts would not function if one of the parts was removed, so supposedly could not have evolved by successive small modifications from earlier less complex systems through natural selection, which would need all intermediate precursor systems to have been fully functional. Irreducible complexity has become central to the creationist concept of intelligent design, but the concept of irreducible complexity has been rejected by the scientific community, which regards intelligent design as pseudoscience. Irreducible complexity is one of two main arguments used by intelligent-design proponents to support their version of the theological argument from design, used alongside specified complexity which adds mathematical support for it.

<i>Escherichia coli</i> Enteric, rod shaped, gram-negative bacterium

Escherichia coli, also known as E. coli, is a Gram-negative, facultative anaerobic, rod-shaped, coliform bacterium of the genus Escherichia that is commonly found in the lower intestine of warm-blooded organisms. Most E. coli strains are harmless, but some serotypes (EPEC, ETEC etc.) can cause serious food poisoning in their hosts, and are occasionally responsible for food contamination incidents that prompt product recalls. Most strains do not cause disease in humans and are part of the normal microbiota of the gut; such strains are harmless or even beneficial to humans (although these strains tend to be less studied than the pathogenic ones). For example, some strains of E. coli benefit their hosts by producing vitamin K2 or by preventing the colonization of the intestine by pathogenic bacteria. These mutually beneficial relationships between E. coli and humans are a type of mutualistic biological relationship — where both the humans and the E. coli are benefitting each other. E. coli is expelled into the environment within fecal matter. The bacterium grows massively in fresh faecal matter under aerobic conditions for three days, but its numbers decline slowly afterwards.

<span class="mw-page-title-main">Carl Woese</span> American microbiologist who identified Archaea (1928–2012)

Carl Richard Woese was an American microbiologist and biophysicist. Woese is famous for defining the Archaea in 1977 through a pioneering phylogenetic taxonomy of 16S ribosomal RNA, a technique that has revolutionized microbiology. He also originated the RNA world hypothesis in 1967, although not by that name. Woese held the Stanley O. Ikenberry Chair and was professor of microbiology at the University of Illinois at Urbana–Champaign.

<span class="mw-page-title-main">Horizontal gene transfer</span> Type of nonhereditary genetic change

Horizontal gene transfer (HGT) or lateral gene transfer (LGT) is the movement of genetic material between unicellular and/or multicellular organisms other than by the ("vertical") transmission of DNA from parent to offspring (reproduction). HGT is an important factor in the evolution of many organisms. HGT is influencing scientific understanding of higher order evolution while more significantly shifting perspectives on bacterial evolution.

<span class="mw-page-title-main">Experimental evolution</span> Use of laboratory and field experiments to explore evolutionary dynamics

Experimental evolution is the use of laboratory experiments or controlled field manipulations to explore evolutionary dynamics. Evolution may be observed in the laboratory as individuals/populations adapt to new environmental conditions by natural selection.

<span class="mw-page-title-main">Geobiology</span>

Geobiology is a field of scientific research that explores the interactions between the physical Earth and the biosphere. It is a relatively young field, and its borders are fluid. There is considerable overlap with the fields of ecology, evolutionary biology, microbiology, paleontology, and particularly soil science and biogeochemistry. Geobiology applies the principles and methods of biology, geology, and soil science to the study of the ancient history of the co-evolution of life and Earth as well as the role of life in the modern world. Geobiologic studies tend to be focused on microorganisms, and on the role that life plays in altering the chemical and physical environment of the pedosphere, which exists at the intersection of the lithosphere, atmosphere, hydrosphere and/or cryosphere. It differs from biogeochemistry in that the focus is on processes and organisms over space and time rather than on global chemical cycles.

<span class="mw-page-title-main">Richard Lenski</span> American evolutionary biologist

Richard Eimer Lenski is an American evolutionary biologist, a Hannah Distinguished Professor of Microbial Ecology at Michigan State University. He is a member of the National Academy of Sciences and a MacArthur fellow. Lenski is best known for his still ongoing 34-year-old long-term E. coli evolution experiment, which has been instrumental in understanding the core processes of evolution, including mutation rates, clonal interference, antibiotic resistance, the evolution of novel traits, and speciation. He is also well known for his pioneering work in studying evolution digitally using self-replicating organisms called Avida.

<span class="mw-page-title-main">Chemostat</span>

A chemostat is a bioreactor to which fresh medium is continuously added, while culture liquid containing left over nutrients, metabolic end products and microorganisms is continuously removed at the same rate to keep the culture volume constant. By changing the rate with which medium is added to the bioreactor the specific growth rate of the microorganism can be easily controlled within limits.

Allan McCulloch Campbell was an American microbiologist and geneticist and the Barbara Kimball Browning Professor Emeritus in the Department of Biology at Stanford University. His pioneering work on Lambda phage helped to advance molecular biology in the late 20th century. An important collaborator and member of his laboratory at Stanford University was biochemist Alice del Campillo Campbell, his wife.

<span class="mw-page-title-main">Esther Lederberg</span> American microbiologist and a pioneer of bacterial genetics

Esther Miriam Zimmer Lederberg was an American microbiologist and a pioneer of bacterial genetics. She discovered the bacterial virus λ and the bacterial fertility factor F, devised the first implementation of replica plating, and furthered the understanding of the transfer of genes between bacteria by specialized transduction.

<span class="mw-page-title-main">History of model organisms</span>

The history of model organisms began with the idea that certain organisms can be studied and used to gain knowledge of other organisms or as a control (ideal) for other organisms of the same species. Model organisms offer standards that serve as the authorized basis for comparison of other organisms. Model organisms are made standard by limiting genetic variance, creating, hopefully, this broad applicability to other organisms.

<span class="mw-page-title-main">Bacteria</span> Domain of micro-organisms

Bacteria are ubiquitous, mostly free-living organisms often consisting of one biological cell. They constitute a large domain of prokaryotic microorganisms. Typically a few micrometres in length, bacteria were among the first life forms to appear on Earth, and are present in most of its habitats. Bacteria inhabit soil, water, acidic hot springs, radioactive waste, and the deep biosphere of Earth's crust. Bacteria are vital in many stages of the nutrient cycle by recycling nutrients such as the fixation of nitrogen from the atmosphere. The nutrient cycle includes the decomposition of dead bodies; bacteria are responsible for the putrefaction stage in this process. In the biological communities surrounding hydrothermal vents and cold seeps, extremophile bacteria provide the nutrients needed to sustain life by converting dissolved compounds, such as hydrogen sulphide and methane, to energy. Bacteria also live in symbiotic and parasitic relationships with plants and animals. Most bacteria have not been characterised and there are many species that cannot be grown in the laboratory. The study of bacteria is known as bacteriology, a branch of microbiology.

<span class="mw-page-title-main">Medical microbiology</span> Branch of medical science

Medical microbiology, the large subset of microbiology that is applied to medicine, is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health. There are four kinds of microorganisms that cause infectious disease: bacteria, fungi, parasites and viruses, and one type of infectious protein called prion.

Mycoplasma laboratorium or Synthia refers to a synthetic strain of bacterium. The project to build the new bacterium has evolved since its inception. Initially the goal was to identify a minimal set of genes that are required to sustain life from the genome of Mycoplasma genitalium, and rebuild these genes synthetically to create a "new" organism. Mycoplasma genitalium was originally chosen as the basis for this project because at the time it had the smallest number of genes of all organisms analyzed. Later, the focus switched to Mycoplasma mycoides and took a more trial-and-error approach.

<span class="mw-page-title-main">Microbiology</span> Study of microscopic organisms

Microbiology is the scientific study of microorganisms, those being unicellular, multicellular, or acellular. Microbiology encompasses numerous sub-disciplines including virology, bacteriology, protistology, mycology, immunology, and parasitology.

Pathogenomics is a field which uses high-throughput screening technology and bioinformatics to study encoded microbe resistance, as well as virulence factors (VFs), which enable a microorganism to infect a host and possibly cause disease. This includes studying genomes of pathogens which cannot be cultured outside of a host. In the past, researchers and medical professionals found it difficult to study and understand pathogenic traits of infectious organisms. With newer technology, pathogen genomes can be identified and sequenced in a much shorter time and at a lower cost, thus improving the ability to diagnose, treat, and even predict and prevent pathogenic infections and disease. It has also allowed researchers to better understand genome evolution events - gene loss, gain, duplication, rearrangement - and how those events impact pathogen resistance and ability to cause disease. This influx of information has created a need for bioinformatics tools and databases to analyze and make the vast amounts of data accessible to researchers, and it has raised ethical questions about the wisdom of reconstructing previously extinct and deadly pathogens in order to better understand virulence.

Pathogenic <i>Escherichia coli</i> Strains of E. coli that can cause disease

Escherichia coli is a gram-negative, rod-shaped bacterium that is commonly found in the lower intestine of warm-blooded organisms (endotherms). Most E. coli strains are harmless, but pathogenic varieties cause serious food poisoning, septic shock, meningitis, or urinary tract infections in humans. Unlike normal flora E. coli, the pathogenic varieties produce toxins and other virulence factors that enable them to reside in parts of the body normally not inhabited by E. coli, and to damage host cells. These pathogenic traits are encoded by virulence genes carried only by the pathogens.

The host–pathogen interaction is defined as how microbes or viruses sustain themselves within host organisms on a molecular, cellular, organismal or population level. This term is most commonly used to refer to disease-causing microorganisms although they may not cause illness in all hosts. Because of this, the definition has been expanded to how known pathogens survive within their host, whether they cause disease or not.

<span class="mw-page-title-main">Heather Hendrickson</span> American-born New Zealand-based microbiologist

Heather Hendrickson is a microbiologist and a Senior Lecturer in the School of Biological Sciences at the University of Canterbury in Christchurch, New Zealand. She previously worked at Massey University, Auckland, New Zealand. Her research is focussed on the evolution of bacterial cell shape, and the discovery of bacteriophages that can attack antibiotic-resistant bacteria and the bee disease American foulbrood.

References

  1. Steven Novella (21 May 2008). "SGU Episode 148". www.theskepticsguide.org (Podcast). The Skeptics Guide to the Universe. Event occurs at 39:25. Retrieved 23 February 2019.
  2. 1 2 Peter Dizikes (29 June 2008). "E. Coli and You". The New York Times. Retrieved 23 February 2019.
  3. 1 2 Jon Turney (9 July 2008). "Microcosm: E.coli And The New Science Of Life, by Carl Zimmer" . The Independent. Archived from the original on 2022-05-14. Retrieved 23 February 2019.
  4. 1 2 3 4 Nataro, James P. (December 1, 2008). "Book Review: Microcosm: E. coli and the new science of life". The Journal of Clinical Investigation. 118 (12): 3818. doi:10.1172/JCI37541. PMC   2586741 .